News for 'drug quality'

Karnataka bans social media for children under 16

Karnataka bans social media for children under 16

Rediff.com6 Mar 2026

Karnataka Chief Minister announces a ban on social media for children under 16 and increased measures to prevent drug abuse in schools, colleges, and universities, alongside investments in education infrastructure and mental health support.

GST cut on drugs, medical devices to help patients

GST cut on drugs, medical devices to help patients

Rediff.com4 Sep 2025

The government's move to cut GST on medicines and medical devices while exempting lifesaving drugs from the levy is a bold step that will bring direct relief to patients and families while significantly reducing financial strain on them, pharmaceuticals and healthcare industry players said on Thursday.

India launches nationwide HPV vaccination drive

India launches nationwide HPV vaccination drive

Rediff.com24 Feb 2026

The Indian government is set to launch a nationwide HPV vaccination program targeting 14-year-old girls to prevent cervical cancer, utilizing a single-dose vaccine and aiming for equitable access across socio-economic groups.

Indian pharma to get stronger dose of EU mkt access

Indian pharma to get stronger dose of EU mkt access

Rediff.com5 Feb 2026

The European Union's (EU's) offer to slash tariffs on 97.5 per cent of Indian chemical exports to zero is set to give India's pharmaceutical and medical device firms preferential access to the European markets.

Coldrif syrup maker used industrial-grade materials: ED

Coldrif syrup maker used industrial-grade materials: ED

Rediff.com3 Dec 2025

An Enforcement Directorate (ED) probe has revealed that the manufacturer of Coldrif syrup, linked to the deaths of at least 20 children in Madhya Pradesh, used industrial-grade raw materials without quality checks. The investigation also found that Tamil Nadu Drugs Control Department officials were in frequent contact with the company but failed to conduct mandated inspections.

HC quashes licence cancellation of drug firm linked to Uzbek deaths

HC quashes licence cancellation of drug firm linked to Uzbek deaths

Rediff.com15 Jun 2025

Justice Dinesh Pathak, allowing a writ petition filed by M/s Marion Biotech Private Limited, observed that he was surprised that Indian authorities are "trying to validate their proceedings" based on the judgement of the Supreme Court of the Republic of Uzbekistan.

Cough syrup deaths: Many states ban Coldrif; MP suspends officials

Cough syrup deaths: Many states ban Coldrif; MP suspends officials

Rediff.com7 Oct 2025

A special investigation team (SIT) has been formed in Madhya Pradesh to investigate the deaths of 14 children in Chhindwara, suspected to be linked to a toxic cough syrup. The investigation includes arrests, exhumations, and a ban on the implicated cough syrup.

Abolish or reduce tax on air purifiers in Delhi, HC tells GST Council

Abolish or reduce tax on air purifiers in Delhi, HC tells GST Council

Rediff.com24 Dec 2025

The Delhi High Court has directed the GST Council to consider lowering or abolishing the goods and services tax on air purifiers, citing worsening air quality in the national capital. The court has asked the council to meet at the earliest, even via video conference if necessary, to address the issue.

Union Budget 2026: Sitharaman tries to cover all bases, leaves out markets

Union Budget 2026: Sitharaman tries to cover all bases, leaves out markets

Rediff.com1 Feb 2026

Budget 2026 sticks to fiscal discipline, shuns populist measures despite five key state elections coming up, but ends up rattling stock markets with a higher transaction tax on derivatives trading.

Govt launches all India drive to test cough syrups

Govt launches all India drive to test cough syrups

Rediff.com9 Oct 2025

The Central Drugs Standard Control Organisation (CDSCO) has initiated a nationwide campaign to test, inspect, and audit cough syrup manufacturers following concerns about contaminated products and child deaths. The initiative aims to ensure adherence to safety standards and regulatory compliance.

A long-game Budget

A long-game Budget

Rediff.com2 Feb 2026

The Union Budget for 2026-27, presented by Finance Minister (FM) Nirmala Sitharaman on Sunday, which was a first, had an excellent domestic macro backdrop. According to the first advance estimates, gross domestic product (GDP) in constant prices is projected to grow 7.4 per cent in the current financial year, against 6.5 per cent in 2024-25.

Cough syrup deaths: IMA slams doctor's arrest

Cough syrup deaths: IMA slams doctor's arrest

Rediff.com7 Oct 2025

The Indian Medical Association (IMA) has defended a doctor arrested in connection with cough syrup deaths in Madhya Pradesh, attributing the incident to failures in the drugs regulatory system.

3 cough syrups have been recalled: India replies to WHO

3 cough syrups have been recalled: India replies to WHO

Rediff.com9 Oct 2025

India's drug regulator CDSCO has recalled three cough syrups and halted their production after the WHO raised concerns about potential contamination and links to child deaths. The WHO is investigating reports of pediatric illnesses and deaths in India potentially linked to contaminated syrups.

Is Pharmaceutical Engg Better Than BPham And PharmD?

Is Pharmaceutical Engg Better Than BPham And PharmD?

Rediff.com11 Nov 2025

rediffGURU Nayagam PP advises young aspirants how to pick the right course and career.

Was killer cough syrup exported, asks WHO to India

Was killer cough syrup exported, asks WHO to India

Rediff.com9 Oct 2025

The WHO will take a call on issuing a 'Global Medical Products Alert' on the cough syrup, Coldrif, after receiving an official confirmation from authorities here. The agency issues such alerts for substandard and contaminated medicines.

Ozempic launched in India, priced at Rs 2,200 per week

Ozempic launched in India, priced at Rs 2,200 per week

Rediff.com12 Dec 2025

Danish pharma major Novo Nordisk on Friday launched its blockbuster type 2 diabetes treatment injection Ozempic, globally popular for its weight-loss benefits.

Delhi pollution worsens: HC questions 18% GST on air purifiers

Delhi pollution worsens: HC questions 18% GST on air purifiers

Rediff.com26 Dec 2025

The Delhi High Court has asked the central government why it cannot reduce the GST on air purifiers, considering the poor air quality in Delhi. The court's concern is that the current 18% GST makes air purifiers unaffordable for the common man.

Where The Deadly Cough Syrup Was Made

Where The Deadly Cough Syrup Was Made

Rediff.com18 Oct 2025

Sandwiched between a Hero MotoCorp showroom and a shop that hires out cooking utensils is a small, dingy building that's been locked up. The non-descript two-room building is a manufacturing unit of Sresan Pharmaceuticals, the pharma company made its Coldriff cough syrup that has allegedly killed 25 children in Madhya Pradesh.

Pharma owner arrested over cough syrup that killed 20 children

Pharma owner arrested over cough syrup that killed 20 children

Rediff.com9 Oct 2025

S Ranganathan, the owner of the Tamil Nadu-based pharmaceuticals company that manufactured the Coldrif cough syrup linked to 20 children's deaths, has been arrested.

Cough syrup deaths: No state follows pharma safety norms

Cough syrup deaths: No state follows pharma safety norms

Rediff.com10 Oct 2025

The Central Drugs Standard Control Organisation (CDSCO) will conduct testing, inspection and auditing of cough syrup manufacturers.

Mankind Pharma Targets Anti-Obesity Drug

Mankind Pharma Targets Anti-Obesity Drug

Rediff.com6 Mar 2025

'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.'

Adulterated Drugs On Decline Amid Crackdown

Adulterated Drugs On Decline Amid Crackdown

Rediff.com10 Oct 2024

Rise in raids on illicit drug manufacturing units, alongside arrests for the production, sale, or distribution of spurious or adulterated drugs.

Planning To Freeze Your Eggs? What You Must Know

Planning To Freeze Your Eggs? What You Must Know

Rediff.com2 Dec 2025

Dr Sulbha Arora, clinical director and fertility specialist at Nova IVF Fertility, explains everything you need to know about egg freezing in India, including the process, the cost and the risks involved.

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Rediff.com26 Sep 2025

Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.

Rajasthan govt bans cough syrup after children's deaths

Rajasthan govt bans cough syrup after children's deaths

Rediff.com2 Oct 2025

A generic cough syrup supplied to the Rajasthan government has been linked to the deaths of two children and others falling sick in the state, prompting authorities to ban 22 batches of the drug and order an inquiry.

Tylenol row may not hit India's pharma exports

Tylenol row may not hit India's pharma exports

Rediff.com29 Sep 2025

Amid controversy over USPresident Donald Trump's comments linking the use of Tylenol and other related paracetamol products by pregnant women to autism in children, experts and industry executives say that since India's export of the drug to the US is less, it will hardly affect the country's pharma exports to America.

'Goa Nightclub Fire Was Murder!'

'Goa Nightclub Fire Was Murder!'

Rediff.com9 Dec 2025

'When an establishment operates despite demolition or closure orders, without proper fire exits, evacuation plans or safety audits, and yet is allowed to host large crowds, the state cannot hide behind the language of accident.' 'The authorities were aware of the risks and of the violations, but chose not to act decisively because doing so would have inconvenienced those with influence and financial stakes.' 'In such a scenario, the moral and legal responsibility for the resulting deaths moves from negligence towards culpability; calling it 'murder' is a way of underlining that these lives were sacrificed at the altar of greed and complicity, not fate.'

Indian pharma eyes US gains as $63.7 bn patent cliff nears

Indian pharma eyes US gains as $63.7 bn patent cliff nears

Rediff.com30 Jun 2025

The Indian pharmaceutical industry is likely to benefit from a major wave of patent expiries in the US, as small-molecule drugs worth $63.7 billion are expected to go off-patent between 2025-29, a 65 per cent rise over the previous five years, according to a report by Antique stock broking limited.

WHO issues alert against Indian cough syrups. They are...

WHO issues alert against Indian cough syrups. They are...

Rediff.com14 Oct 2025

The World Health Organisation (WHO) has issued an alert against three "substandard" oral cough syrups identified in India and urged national regulatory authorities worldwide to immediately notify it if these are detected in their country.

Quality perceptions hobble Jan Aushadi drugs

Quality perceptions hobble Jan Aushadi drugs

Rediff.com10 Oct 2018

Large pharmaceutical firms feel that if the quality parameters and assurance levels are brought up to the level of branded generics, then Jan Aushadhi medicines would find it difficult to retain their affordability.

India's Space Manufacturing Boom

India's Space Manufacturing Boom

Rediff.com15 Aug 2025

The $1.2 billion in-space manufacturing market is expected to grow and be worth more than $20 billion by 2033.

Caterer's licence suspended after Shiv Sena MLA's assault

Caterer's licence suspended after Shiv Sena MLA's assault

Rediff.com10 Jul 2025

The Maharashtra Food and Drugs Administration (FDA) has suspended the license of a caterer that operates the canteen at the MLA hostel in Mumbai, after a Shiv Sena legislator assaulted a staffer for allegedly serving stale food.

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Rediff.com31 Jul 2025

India's pharmaceuticals and medical devices industries are still hopeful that trade negotiations with the US could cut a fairer deal for both sides, after President Donald Trump announced a 25 per cent tariff rate on India on a social networking platform without divulging the finer details.

States Seek Centre's Help To Deal With Trump's Tariffs

States Seek Centre's Help To Deal With Trump's Tariffs

Rediff.com2 Sep 2025

State governments have requested the Centre for export incentives, lifting of import duty in the case of cotton for the textile sector and GST exemptions.

CBI brings back 'meow meow' kingpin from UAE

CBI brings back 'meow meow' kingpin from UAE

Rediff.com11 Jul 2025

An alleged synthetic narcotics producer, Kubbawala Mustafa, wanted on an Interpol Red Notice, was deported to India from the UAE in an operation coordinated by the CBI and Mumbai police.

Lokah Review: Intriguing!

Lokah Review: Intriguing!

Rediff.com1 Sep 2025

The Kalyani Priyadarshan starrer is the kind of incentive superhero origin story that can alter the way such films are made in Malayalam cinema, feels Arjun Menon.

The C P Radhakrishnan You Didn't Know

The C P Radhakrishnan You Didn't Know

Rediff.com9 Sep 2025

'In my 26 years at Raj Bhavan, working with more than ten governors, I can tell you C P Radhakrishnan Sir stands out.'

Record 3,300 kg of drugs seized off Gujarat coast in major drug haul

Record 3,300 kg of drugs seized off Gujarat coast in major drug haul

Rediff.com29 Feb 2024

The drugs seized include 3,089 kilograms of charas, 158 kg of Methamphetamine and 25 kg of morphine.

Why Drug Prices Won't Increase This Year

Why Drug Prices Won't Increase This Year

Rediff.com5 Apr 2024

The government has been stringent with pricing changes. Prices of 651 essential medicines came down from April 1, 2023 by 6.73 per cent with the government capping ceiling prices of these drugs.

Shortcuts Won't Build Industrial Capability

Shortcuts Won't Build Industrial Capability

Rediff.com28 Jul 2025

Any industrial policy is only as good as how it is applied and the other reforms that support it. This was as true 40 years ago as it is now, points out Debashis Basu.